Delestrogen Alternatives Compared
Delestrogen (estradiol) | Pluvicto (lutetium lu 177 vipivotide tetraxetan) | Bicalutamide |
|
---|
Delestrogen (estradiol) | Pluvicto (lutetium lu 177 vipivotide tetraxetan) | Bicalutamide |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Atrophic Vaginitis, Postmenopausal Symptoms, Atrophic Urethritis, Hypoestrogenism, Oophorectomy, Primary Ovarian Failure, Prostate Cancer. Delestrogen may also be used for purposes not... View more |
Prescription only
Prescribed for Prostate Cancer. Pluvicto may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer. Bicalutamide may also be used for purposes not listed in this medication guide. |
Related suggestions Prostate Cancer
|
|||||||||||||||||||||||
More about Delestrogen (estradiol) | More about Pluvicto (lutetium lu 177 vipivotide tetraxetan) | More about Bicalutamide | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Delestrogen has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Pluvicto has an average rating of 8.0 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
Bicalutamide has an average rating of 8.4 out of 10 from a total of 13 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Delestrogen side effects |
View all Pluvicto side effects |
View all Bicalutamide side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Delestrogen prices |
View all Pluvicto prices |
View all Bicalutamide prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other estradiol brands include: Alora, Climara, Depo-Estradiol, Divigel, Dotti, Elestrin, Estra Pellets, Estrace, Estraderm, Estradiol Patch, Estrogel, Evamist, Femring, Lyllana, Menostar, Minivelle, Vivelle-Dot View more |
N/A |
Casodex | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
16 hours |
41.6 hours |
240 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 392 drugs are known to interact with Delestrogen:
|
A total of 219 drugs are known to interact with Pluvicto:
|
A total of 383 drugs are known to interact with Bicalutamide:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
March 23, 2022 |
October 04, 1995 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.